Global Leadership in Interventional Cardiology
Insights & Education
Welcome to my clinical video library, featuring highlights from my presentations at international cardiology congresses and global medical summits. As an internally recognised Key Opinion Leader (KOL) in interventional cardiology, I am dedicated to advancing the field of heart valve disease and complex coronary interventions.
Innovation, Research, and Physician Training
These videos showcase my commitment to the future of cardiovascular medicine through:
Pioneering Research: Presenting the latest clinical trial data and evidence-based heart treatments to global audiences.
Physician Education: Demonstrating advanced techniques to train the next generation of cardiologists and heart teams.
Medical Innovation: Engaging with global leaders to refine minimally invasive procedures such as TAVI and Mitral TEER.
By sharing these insights from the world’s leading cardiology stages, my goal is to bridge the gap between cutting-edge research and the personalised, high-standard care I provide to my patients in the clinic.
2025 ESC/EACTS Valvular Heart Disease Guidelines Discussion
In this session, Dr Cook serves as the anchor for a high-level clinical discussion regarding the newly released 2025 ESC/EACTS Guidelines for the management of valvular heart disease. This presentation focuses on the shifting paradigms in treating severe aortic stenosis, specifically highlighting the expanded role of Transcatheter Aortic Valve Implantation (TAVI).
Clinical Highlights & Live Case Analysis
This video includes a live case operation, providing a step-by-step demonstration of a TAVI procedure performed under the latest clinical standards. We explore the critical decision-making process involved in selecting the optimal intervention for patients with aortic valve disease.
Key Topics Covered:
TAVI vs. SAVR: Navigating the updated 2025 selection criteria for surgical vs. transcatheter interventions.
Asymptomatic Severe Aortic Stenosis: When to intervene based on the latest evidence-based triggers.
Live Procedural Demonstration: Real-time analysis of TAVI technique and imaging integration.
The Heart Team Approach: How multidisciplinary collaboration has evolved under the new European guidelines.
Expert Insights for Professionals and Patients
Whether you are a cardiology professional seeking to stay current with 2025 ESC/EACTS updates or a patient researching modern treatments for heart valve disease, this session offers a comprehensive look at the future of interventional cardiology and structural heart repair.
Expert Analysis: 2025 ESC/EACTS Heart Valve Guidelines & TAVI
Dr Christopher Cook anchors a clinical roundtable to discuss the 2025 ESC/EACTS Guidelines for valvular heart disease. Featuring a live TAVI case, the session evaluates new evidence-based triggers for early intervention in asymptomatic severe aortic stenosis.
EuroPCR 2025: Breakthroughs in TAVI, Mitral, and Coronary Care
Dr Christopher Cook reviews key highlights from EuroPCR 2025, focusing on structural heart interventions. Topics include complex TAVI (re-do and coronary access), Mitral TEER, and the rapid evolution of Tricuspid replacement devices for regurgitation.
Latest Innovations in Heart Valve Treatment
In this expert discussion, world-leading specialists Christopher Cook, Nicolas Dumonteil, and Bernard Prendergast review the most significant breakthroughs in structural and valvular heart interventions from the EuroPCR 2025 conference.
Advancing TAVI and Aortic Valve Care
The session dives into the latest techniques for TAVI, focusing on how we handle complex cases. We discuss new methods for "re-do" procedures and protecting the heart's arteries (coronary re-access) to ensure long-term safety for patients with Aortic Stenosis.
New Solutions for Mitral and Tricuspid Valves
Mitral Valve: We explore how Edge-to-Edge Repair (TEER) remains the leading minimally invasive option for patients
Tricuspid Valve: This field is evolving rapidly with new repair and replacement devices designed to treat "the forgotten valve" with more precision than ever before.
Evolving Strategy for Asymptomatic Aortic Stenosis
In this professional roundtable from EuroPCR 2025, Dr Christopher Cook joins colleagues Philippe Genereux and Victoria Delgado to evaluate the latest clinical data regarding the timing of intervention for heart valve disease.
New Insights from the EARLY TAVR Study
The discussion focuses on a significant shift in how the medical community views "watchful waiting" for patients with severe aortic stenosis who do not yet show physical symptoms. Dr Cook and the panel examine evidence suggesting that early intervention may offer long-term benefits:
Evidence-Based Treatment: Recent data from the EARLY TAVR study indicates that a more proactive approach—treating the valve before symptoms appear—is increasingly being considered a safe and evidence-based option.
A Precision Approach to Patient Care
Dr Cook explains that determining the optimal moment for intervention is a highly individualised process. Beyond looking for symptoms, he and the expert panel highlight the importance of "staging" a patient's condition.
Summary
The consensus from this expert session is that the field of structural heart disease is moving toward a more nuanced model of care. By considering the latest research, Dr Cook aims to help patients navigate the complex choice between continued monitoring and proactive treatment to ensure the best possible long-term cardiac health.
The EARLY TAVR Study: New Evidence for Aortic Stenosis Treatment
Dr Christopher Cook examines findings from the EARLY TAVR study regarding asymptomatic severe aortic stenosis. The discussion highlights how early TAVI intervention is becoming a recognised evidence-based option to prevent long-term cardiac damage compared to traditional surveillance.
Heart to Heart: Dr Christopher Cook on the Year’s Hottest Topics in Cardiology
In this engaging "Heart to Heart" conversation, Dr Christopher Cook reviews the most significant breakthroughs in interventional cardiology from the past year. As an expert in both coronary and structural interventions, Dr Cook provides a comprehensive look at how these two fields are evolving together to improve patient outcomes.
Advancing Structural & Coronary Care
This episode dives into the most discussed clinical updates of 2024, focusing on the latest evidence-based treatments for complex heart conditions:
TAVI: The latest refinements in Transcatheter Aortic Valve Implantation (TAVI) for treating aortic stenosis.
The Tricuspid Frontier: A look at the rapidly evolving field of Tricuspid Intervention, including new devices for Tricuspid Replacement to treat leakiness (regurgitation) in the "forgotten valve."
Coronary Breakthroughs: New data on Drug-Coated Balloons (DCB) for coronary PCI, offering an alternative or supplement to traditional stenting for opening blocked arteries.
Expertise Across the Spectrum of Heart Health
Dr Cook’s unique background allows him to bridge the gap between treating the heart’s internal plumbing (coronary) and its physical architecture (structural). By staying at the forefront of these "hot topics," he ensures that his patients have access to the full spectrum of modern, minimally invasive cardiac therapies.
2024 Cardiology Updates: TAVI, Tricuspid, and Drug-Coated Balloons
In this "Heart to Heart" conversation, coronary and structural expert Dr Christopher Cook discusses the hottest topics in interventional cardiology. Key updates include TAVI advancements, Tricuspid replacement, and the use of Drug-Coated Balloons (DCB) for coronary PCI.
Tricuspid Valve Intervention: New Research and Technical Innovations
Dr Christopher Cook highlights the rapidly evolving field of Tricuspid Valve care. This session covers new scientific evidence and technical innovations for treating Tricuspid Regurgitation using minimally invasive repair (TEER) and replacement devices.
The New Frontier in Heart Valve Care: Dr Christopher Cook on Tricuspid Innovation
Dr Cook and the panel review the latest scientific evidence that is changing how we treat patients with leaky tricuspid valves (regurgitation). The discussion focuses on how new research is directly impacting clinical practice:
Rapid Technical Innovations: A look at the next generation of minimally invasive clips and replacement valves designed specifically for the unique shape of the tricuspid valve.
Evidence-Based Treatment: How new clinical trials are proving that interventional repair can significantly improve a patient’s quality of life and reduce symptoms like fatigue and swelling.
Overcoming Complex Challenges: The experts discuss the technical precision required to perform these procedures safely and effectively using the latest imaging technology.
Leading the Way in Structural Heart Disease
As an expert in structural heart interventions, Dr Cook remains dedicated to bringing these rapidly evolving therapies to his patients. By participating in these global discussions, Dr Cook ensures his practice is aligned with the very latest international standards, offering patients the most advanced options for long-term heart health.
Mitral TEER: 20 Years of Innovation in Heart Valve Repair
Dr Christopher Cook reviews 20 years of progress in Mitral TEER (Edge-to-Edge Repair). This session focuses on contemporary practice for mitral regurgitation, the importance of 3D imaging guidance, and long-term data supporting this minimally invasive solution.
20 Years of Success in Mitral TEER
In this session from the PCR London Valves conference, Dr Christopher Cook joins the discussion highlighting the latest progress in treating Mitral Regurgitation (a leaky mitral valve).
Key Highlights for Patients
Celebrating 20 Years of TEER: The experts mark two decades since the first TEER (Transcatheter Edge-to-Edge Repair) procedure, and how minimally invasive TEER techniques continues to help patients avoid open-heart surgery.
The Power of 3D Imaging: A major takeaway is the vital role of advanced heart imaging. Dr Cook emphasises that using high-resolution scans is now a "key component" for any specialist team, ensuring that every procedure is planned and performed with pinpoint accuracy.
Evidence of Better Outcomes: The panel reviews new data confirming that modern mitral repair is a highly effective, contemporary solution for restoring heart function and improving a patient's quality of life.
A Future-Focused Approach
As an expert in structural heart interventions, Dr Christopher Cook uses these global insights to provide his patients with the most advanced, evidence-based care. By combining twenty years of clinical success with the latest imaging technology, he ensures a sophisticated approach to heart valve health.
Precision in TAVI: Dr Christopher Cook on Valve Selection and Patient Safety
In this clinical deep-dive, Dr Christopher Cook joins a panel of specialists to discuss how the latest advancements in Transcatheter Heart Valve design are improving long-term outcomes for patients.
Inside the Procedure: A TAVI Case by Dr Cook
A standout feature of this video is a recorded TAVI procedure performed by Dr Christopher Cook himself. By watching Dr Cook in action, patients can see the high level of technical precision and advanced imaging used to place a new heart valve through a minimally invasive "keyhole" approach.
Dr Christopher Cook performs a recorded TAVI procedure, demonstrating the precision required for successful transcatheter aortic valve implantation. The discussion evaluates transcatheter heart valve design and its impact on long-term patient safety.
Planning for the Future: Dr Christopher Cook on Lifetime Heart Care
Expert Highlights: TAVI and Long-Term Success
Dr Cook and the panel explore the latest data supporting TAVI, particularly for patients over 70. Key discussion points include:
Valve Durability: New long-term evidence confirming how well modern heart valves perform over many years.
Future-Proofing Your Heart: The importance of choosing the right initial valve to ensure doctors can easily access the heart’s arteries (coronary access) for any future treatments.
Aortic Regurgitation: Breakthroughs in treating "leaky" aortic valves, highlighted by the successful results of the ALIGN-AR clinical trial.
The Power of Advanced Imaging
The session emphasises that successful outcomes rely on Multimodality Imaging. Dr Cook explains how using a combination of high-tech scans allows for a "digital blueprint" of the heart, ensuring every procedure is planned with pinpoint accuracy.
For Dr Christopher Cook, heart care isn't just about the procedure today; it’s about a lifetime of health. By staying at the forefront of global research, he ensures his patients receive treatment that is not only effective now but designed to last a lifetime.
TAVI & Aortic Valve Lifetime Management | PCR London Valves Highlights
Dr Christopher Cook discusses the lifetime management of aortic valve disease. This session evaluates new long-term data for TAVI in patients over 70, focusing on valve durability and coronary access. It also covers the ALIGN-AR trial for Aortic Regurgitation and the role of multimodality imaging in structural heart interventions.
Get in Touch
For the fastest access to appointments:
Please use our Book an Appointment portal to view current availability in Essex and London.
For all other enquiries:
Please contact my medical secretary, who will be happy to assist you with scheduling, billing, or clinical queries.
Phone: 020 4615 3086
Response Time: We aim to respond to all enquiries within 24 hours (Mon–Fri).